Lanying Du

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Wanbo Tai, Lei He, Xiujuan Zhang et al. · Cellular and Molecular Immunology · 2020 · 1.8K citations · Full text

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Shuai Xia, Meiqin Liu, Chao Wang et al. · Cell Research · 2020 · 1.4K citations · Full text

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Shibo Jiang, Christopher D. Hillyer, Lanying Du · Trends in Immunology · 2020 · 934 citations · Full text

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Yushun Wan, Jian Shang, Shihui Sun et al. · Journal of Virology · 2019 · 696 citations · Full text

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

Shuai Xia, Lei Yan, Wei Xu et al. · Science Advances · 2019 · 515 citations · Full text